In this study, we have shown that TROP2 expression is increased in the early stages of neoplastic transformation of the intestinal epithelium in humans and mice, and that a high TROP2 expression is present in approximately one quarter of the analyzed CRC cases. This evidence concerns the gene TACSTD2 and colorectal carcinoma.